Melittin for Treating Rheumatoid Arthritis
Author Information
Author(s): Pareek Ashutosh, Mehlawat Khushbu, Tripathi Kritika, Pareek Aaushi, Chaudhary Simran, Ratan Yashumati, Apostolopoulos Vasso, Chuturgoon Anil
Primary Institution: Banasthali Vidyapith
Hypothesis
Can melittin from bee venom be an effective therapeutic agent for rheumatoid arthritis?
Conclusion
Melittin shows significant anti-inflammatory effects and potential as a treatment for rheumatoid arthritis, despite its cytotoxicity.
Supporting Evidence
- Melittin downregulates inflammatory cytokines like TNF-α and IL-6.
- Recent delivery systems aim to reduce melittin's toxicity.
- Melittin has shown efficacy in various animal models of arthritis.
- Bee venom has been used in traditional medicine for centuries.
- Melittin's mechanism involves inhibition of NF-κB signaling.
- Nanocarrier systems are being developed to enhance melittin's therapeutic potential.
- Melittin can disrupt cell membranes, leading to cytotoxic effects.
- Combination therapies with melittin may enhance its efficacy and reduce toxicity.
Takeaway
Melittin, a substance from bee venom, can help reduce inflammation in arthritis, but it can also be harmful to cells.
Methodology
The review summarizes the composition of bee venom, the mechanisms of melittin's antiarthritic effects, and recent advancements in delivery systems.
Potential Biases
Potential bias in the review due to the focus on melittin without extensive clinical trial data.
Limitations
Melittin's hemolytic activity and cytotoxic effects limit its therapeutic application.
Participant Demographics
Rheumatoid arthritis affects about 1% of the population, with a higher prevalence in women and older adults.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website